MedPath

PULMORPHAN

PULMORPHAN

Dormant
DIN Number

00513741

Drug Class

Human

Market Date

Dec 31, 1978

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00513741
AIG Number0414413001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

DEXTROMETHORPHAN HYDROBROMIDEActive
Strength: 10 MG / 5 ML
Monograph: DEXTROMETHORPHAN HYDROBROMIDE
GUAIFENESINActive
Strength: 50 MG / 5 ML
Monograph: GUAIFENESIN
PHENIRAMINE MALEATEActive
Strength: 7.5 MG / 5 ML
Monograph: PHENIRAMINE MALEATE
PHENYLEPHRINE HYDROCHLORIDEActive
Strength: 3.75 MG / 5 ML
Monograph: PHENYLEPHRINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.